ARTIGO ORIGINAL
Algarve Médico, 2019; 9 (3): 16 - 21
ORIGINAL ARTICLE
The comorbidities with higher impact in a Ménière’s Disease population Mafalda Silva Ferreira1, Joana Gonçalves1, Isa Elói1, Ana Margarida Amorim2, Luís Silva2 1 2
ENT Department, Coimbra University Hospital, Coimbra, Portugal Vestibular Unit, ENT Department, Coimbra University Hospital, Coimbra, Portugal
mafalda.sf1990@gmail.com
Abstract Introduction: Recurrent vertigo episodes, unilateral sensorineural hearing loss and fluctuating aural symptoms characterize Ménière’s Disease (MD). It is a multifactorial disorder where genetics and environmental factors play a role on the onset of these disease. Much is known about its physiopathology, but there is a lack of information about which comorbidities affect such patients. The aim of this study is to evaluate which comorbilities have higher impact in Ménière Disease. Material and methods: This is a retrospective and comparative study which characterizes a population of 48 patients with MD followed in the vestibular unit of Coimbra University Hospital. It analyzes which are the comorbidities with greater impact through comparison with an equal population of patients with vestibular neuritis (VN). Results: Mean age of patients with Ménière’s Disease was 54,7 years and the majority were female. Most of MD patients rarely had crises, 89,1% of them were medicated with oral betahistine and 43,9% with diuretics. MD patients have more comorbidities than those with VN. Gastrointestinal, osteoarticular, headaches, and anxiety plus depression were significantly more prevalent in patients with MD. Conclusions: We have demonstrated that MD patients are more likely to have comorbidities, and these may even be associated with MD onset. Knowing better the complex nature of a MD patient helps us to effectively control the disease and, who knows, to prevent it. Keywords: Ménière Disease, Vestibular Neuritis, Vertigo, Endolymphatic hydrops
16
